New MRI dye shows promise for sharper body scans
NCT ID NCT03986138
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study tested a new contrast agent called gadopiclenol to see if it makes body MRI scans clearer. 324 adults with known or suspected lesions in their body took part. The goal was to see if the enhanced scans helped doctors see lesion borders, internal details, and contrast better than scans without contrast. The results could improve how doctors detect and diagnose problems in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LESION IN BODY REGION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acibadem City Clinic Tokuda Hospital Sofia
Sofia, Bulgaria
-
Axis Heilsa S de R.L. de C.V - Althian Clinical Research Management Center
Monterrey, Mexico
-
Borys Clinic
Kyiv, Ukraine
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Bucheon Suncheonhyang Hospital
Gyeonggi-do, South Korea
-
CHU
Angers, France
-
CHU Beaujon
Clichy, France
-
Centrum Medyczne Affidea Wałbrzych
Wałbrzych, Poland
-
Clinical Research Institute S.C.
Estado de México, Mexico
-
Hospital Universitario y Politécnico La Fe
Valencia, Spain
-
Hôpital Saint Louis
Paris, France
-
Inje University Busan Paik Hospital
Busan, South Korea
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Naples, Italy
-
Jagiellońskie Centrum Innowacji Sp. z o. o.
Krakow, Poland
-
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
Szolnok, Hungary
-
Klinik für Diagnostische und Interventionelle Radiologie
Aachen, Germany
-
Korea University Anam Hospital
Seoul, South Korea
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Somogy Megyei Kaposi Mor Oktato Korhaz
Kaposvár, Hungary
-
St. Luke's Hospital
Kropyvnytskyi, Ukraine
-
Szpital Uniwersytecki Nr 1 im. dr Antoniego Jurasza w Bydgoszczy
Bydgoszcz, Poland
-
Szpital Świętego Rafała
Krakow, Poland
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
The University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
UConn Health - University of Connecticut
Farmington, Connecticut, 06030-2802, United States
-
UT Health San Antonio
San Antonio, Texas, 78207, United States
-
University Hospital Jena
Jena, Germany
-
University of Missouri Health System
Columbia, Missouri, 65212, United States
-
Universitätsklinikum Halle
Halle, Germany
-
Universitätsklinikum des Saarlandes
Homburg, Germany
-
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Conditions
Explore the condition pages connected to this study.